Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jocelyn S Garland. (2014) Elevated body mass index as a risk factor for chronic kidney disease: current perspectives. Diabetes, Metabolic Syndrome and Obesity 7, pages 347-355.
Read now
Read now
Omar F. Khabour, Suha H. Wehaibi, Sayer I. Al-Azzam, Karem H. Alzoubi & Zeyad J. El-Akawi. (2013) Association of Adiponectin with Hypertension in Type 2 Diabetic Patients: the Gender Effect. Clinical and Experimental Hypertension 35:5, pages 361-366.
Read now
Read now
Articles from other publishers (27)
Ming Yang, Yan Liu, Shilu Luo, Ying Xiao, Chanyue Zhao & Lin Sun. (2023) Renal lipid deposition and diabetic nephropathy. Diabetic Nephropathy 3:2, pages 17-24.
Crossref
Crossref
怡锋 焦. (2023) Study on the Correlation between Adiponectin and Its Gene Polymorphism and Diabetic Complications. Advances in Clinical Medicine 13:06, pages 9247-9256.
Crossref
Crossref
Yudan Zhang, Yingying Cai, Hongbin Zhang, Jiajun Zhang, Yanmei Zeng, Cunxia Fan, Shaozhou Zou, Chunyan Wu, Shu Fang, Ping Li, Xiaochun Lin, Ling Wang & Meiping Guan. (2021) Brown adipose tissue transplantation ameliorates diabetic nephropathy through the miR-30b pathway by targeting Runx1. Metabolism 125, pages 154916.
Crossref
Crossref
Sonja Lindfors, Zydrune Polianskyte-Prause, Rim Bouslama, Eero Lehtonen, Miia Mannerla, Harry Nisen, Jukka Tienari, Hanne Salmenkari, Richard Forsgård, Tuomas Mirtti, Markku Lehto, Per-Henrik Groop & Sanna Lehtonen. (2021) Adiponectin receptor agonist AdipoRon ameliorates renal inflammation in diet-induced obese mice and endotoxin-treated human glomeruli ex vivo. Diabetologia 64:8, pages 1866-1879.
Crossref
Crossref
Ke-Xue Li, Miao-Jin Ji & Hai-Jian Sun. (2021) An updated pharmacological insight of resveratrol in the treatment of diabetic nephropathy. Gene 780, pages 145532.
Crossref
Crossref
M. E. Statsenko, S. V. Fabritskaya & Y. A. Ryndina. (2020) Kidney damage in patients with chronic heart failure and obesity: the role of leptin and adiponectin. South Russian Journal of Therapeutic Practice 1:3, pages 54-62.
Crossref
Crossref
Ja. М. Filenko. (2020) Clinical and pathogenetic significance of adipose tissue hormones. PROBLEMS OF UNINTERRUPTED MEDICAL TRAINING AND SCIENCE 39:3, pages 60-66.
Crossref
Crossref
Enoch Appiah Adu‐Gyamfi, Linda Ahenkorah Fondjo, William K.B.A. Owiredu, Armin Czika, William Nelson, Jones Lamptey, Ying‐Xiong Wang & Yu‐Bin Ding. (2019) The role of adiponectin in placentation and preeclampsia. Cell Biochemistry and Function 38:1, pages 106-117.
Crossref
Crossref
Mark E. Pepin, Christoph Koentges, Katharina Pfeil, Johannes Gollmer, Sophia Kersting, Sebastian Wiese, Michael M. Hoffmann, Katja E. Odening, Constantin von zur Mühlen, Philipp Diehl, Peter Stachon, Dennis Wolf, Adam R. Wende, Christoph Bode, Andreas Zirlik & Heiko Bugger. (2019) Dysregulation of the Mitochondrial Proteome Occurs in Mice Lacking Adiponectin Receptor 1. Frontiers in Endocrinology 10.
Crossref
Crossref
Ying‐Ying Cai, Hong‐Bin Zhang, Cun‐Xia Fan, Yan‐Mei Zeng, Shao‐Zhou Zou, Chun‐Yan Wu, Ling Wang, Shu Fang, Ping Li, Yao‐Ming Xue & Mei‐Ping Guan. (2019) Renoprotective effects of brown adipose tissue activation in diabetic mice. Journal of Diabetes 11:12, pages 958-970.
Crossref
Crossref
Yaeni Kim & Cheol Whee Park. (2019) Mechanisms of Adiponectin Action: Implication of Adiponectin Receptor Agonism in Diabetic Kidney Disease. International Journal of Molecular Sciences 20:7, pages 1782.
Crossref
Crossref
Juan M. Moreno, Antonio Tapia, Carlos M. Martinez, Virginia Reverte, Lidia Oltra, Maria Teresa Llinas & Francisco Javier Salazar. (2019) Sex-dependent differences in the adverse renal changes induced by an early in life exposure to a high-fat diet. American Journal of Physiology-Renal Physiology 316:2, pages F332-F340.
Crossref
Crossref
Edward Nehus & Mark Mitsnefes. (2019) Childhood Obesity and the Metabolic Syndrome. Pediatric Clinics of North America 66:1, pages 31-43.
Crossref
Crossref
Brodrick Yeboah Amoah, George Awuku Asare, Francis Agyemang Yeboah, Christian Obirikorang, Bernice Asiedu & Arab Omaima Mohammed. (2018) Biomarkers of renal dysfunction among Ghanaian patients with type 2 diabetes mellitus- a cross-sectional study. International Journal of Diabetes in Developing Countries 38:4, pages 437-444.
Crossref
Crossref
Teodor Kacso, Cosmina Ioana Bondor, Crina Claudia Rusu, Diana Moldovan, Dacian Trinescu, Laura Anca Coman, Maria Ticala, Alexandra Maria Gavrilas & Alina Ramona Potra. (2018) Adiponectin is related to markers of endothelial dysfunction and neoangiogenesis in diabetic patients. International Urology and Nephrology 50:9, pages 1661-1666.
Crossref
Crossref
Alice G. Geagea, Samir Mallat, Charbel F. Matar, Raymond Zerbe, Estelle Filfili, Maria Francis, Hanine Haidar & Abdo Jurjus. (2018) Adiponectin and Inflammation in Health and Disease: An Update. Open Medicine Journal 5:1, pages 20-32.
Crossref
Crossref
Yaeni Kim, Ji Hee Lim, Min Young Kim, Eun Nim Kim, Hye Eun Yoon, Seok Joon Shin, Bum Soon Choi, Yong-Soo Kim, Yoon Sik Chang & Cheol Whee Park. (2018) The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes. Journal of the American Society of Nephrology 29:4, pages 1108-1127.
Crossref
Crossref
Chang Seong Kim, Eun Hui Bae, Seong Kwon Ma, Sue K. Park, Ju Yeon Lee, Wookyung Chung, Kyubeck Lee, Yeong Hoon Kim, Kook-Hwan Oh, Curie Ahn & Soo Wan Kim. (2016) Association of serum adiponectin concentration with aortic arterial stiffness in chronic kidney disease: from the KNOW-CKD study. Clinical and Experimental Nephrology 21:4, pages 608-616.
Crossref
Crossref
A Mascali, O Franzese, S Nisticò, U Campia, D Lauro, C Cardillo, N Di Daniele & M Tesauro. (2016) Obesity and kidney disease: Beyond the hyperfiltration. International Journal of Immunopathology and Pharmacology 29:3, pages 354-363.
Crossref
Crossref
Tomás P. Griffin, William Patrick Martin, Nahidul Islam, Timothy O’Brien & Matthew D. Griffin. (2016) The Promise of Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease. Current Diabetes Reports 16:5.
Crossref
Crossref
Lorena Ortega Moreno, Olga Lamacchia, Massimiliano Copetti, Lucia Salvemini, Concetta De Bonis, Salvatore De Cosmo, Mauro Cignarelli, Vincenzo Trischitta & Claudia Menzaghi. (2015) Serum Adiponectin and Glomerular Filtration Rate in Patients with Type 2 Diabetes. PLOS ONE 10:10, pages e0140631.
Crossref
Crossref
I.M. Kacso, A.R. Potra, C.I. Bondor, D. Moldovan, C. Rusu, I.M. Patiu, S. Racasan, R. Orasan, D. Vladutiu, C. Spanu, A. Rusu, C. Nita, R. Moldovan, B. Ghigolea & G. Kacso. (2015) Adiponectin predicts cardiovascular events in diabetes dialysis patients. Clinical Biochemistry 48:13-14, pages 860-865.
Crossref
Crossref
Cosmina Ioana Bondor, Alina Ramona Potra, Diana Moldovan, Crina Claudia Rusu, Mariana Ciorba Pop, Adriana Muresan, Dan Stefan Vladutiu & Ina Maria Kacso. (2015) Relationship of adiponectin to markers of oxidative stress in type 2 diabetic patients: influence of incipient diabetes-associated kidney disease. International Urology and Nephrology 47:7, pages 1173-1180.
Crossref
Crossref
G. A. Christou & D. N. Kiortsis. (2014) The role of adiponectin in renal physiology and development of albuminuria. Journal of Endocrinology 221:2, pages R49-R61.
Crossref
Crossref
Natalie Sweiss & Kumar Sharma. (2014) Adiponectin effects on the kidney. Best Practice & Research Clinical Endocrinology & Metabolism 28:1, pages 71-79.
Crossref
Crossref
C. Ruster & G. Wolf. (2013) Adipokines promote chronic kidney disease. Nephrology Dialysis Transplantation 28:suppl 4, pages iv8-iv14.
Crossref
Crossref
M. Tesauro, A. Mascali, O. Franzese, S. Cipriani, C. Cardillo & N. Di Daniele. (2012) Chronic Kidney Disease, Obesity, and Hypertension: The Role of Leptin and Adiponectin. International Journal of Hypertension 2012, pages 1-7.
Crossref
Crossref